Showing results (1501-1510 of 3,353) with videos related to

Sort By:
Pageof 336
Pharmacoeconomics|February 1, 2023
Informal Care Costs According to Age and Proximity to Death to Support Cost-Effectiveness AnalysesSaskia de Groot, Irene Santi, Pieter Bakx, et al.
Pharmacoeconomics|February 1, 2023
Filgotinib for Treating Moderately to Severely Active Ulcerative Colitis: An Evidence Review Group Perspective of a NICE Single Technology AppraisalAntoinette D I van Asselt, Nigel Armstrong, Merel Kimman, et al.
Pharmacoeconomics|March 4, 2023
The Cost of Uncontrolled Blood Pressure in Australian General Practice: A Modelling Study Using Electronic Health Records (MedicineInsight)Jacqueline Roseleur, David A Gonzalez-Chica, Gillian Harvey, et al.
Pharmacoeconomics|November 13, 2022
Patient Preferences in Targeted Pharmacotherapy for Cancers: A Systematic Review of Discrete Choice ExperimentsShan Jiang, Ru Ren, Yuanyuan Gu, et al.
Pharmacoeconomics|November 20, 2022
Psychometric Properties of Generic Preference-Weighted Measures for Children and Adolescents: A Systematic ReviewRachel Lee-Yin Tan, Sonia Zhi Yi Soh, Le Ann Chen, et al.
Pharmacoeconomics|February 3, 2023
Cost Effectiveness of Difelikefalin Compared to Standard Care for Treating Chronic Kidney Disease Associated Pruritus (CKD-aP) in People with Kidney Failure Receiving HaemodialysisPraveen Thokala, Pann Ei Hnynn Si, Monica Hernandez Alava, et al.
Pharmacoeconomics|November 3, 2025
Re-anchoring the Value of Innovative Therapies in NICE Decision Making When Comparators are Cost Ineffective: A Case Study of Late-Onset Pompe DiseaseMatthew Walton, Nyanar J Deng, Mark Corbett, et al.
Pharmacoeconomics|November 1, 2025
Caring for and Caring about in Economic Evaluation: Modelling the Family and Caregiving EffectsBecky Pennington, Sarah Davis, Holly Cranmer
Pharmacoeconomics|November 6, 2025
External Validation of the MicroSimulation Core Obesity Model (MS-COM) to Predict Cardiovascular Outcomes, Mortality and Type 2 Diabetes Mellitus Incidence and Assess Cost EffectivenessChristopher G Fawsitt, Howard Thom, David Aceituno, et al.
Pharmacoeconomics|October 5, 2025
The Influence of Perspective on the Valuation of the EQ-5D-Y-3L: A Comparison Using the OPUF Tool and a Discrete Choice ExperimentJake Hitch, Gayathri Kumar, Paul Schneider, et al.
Pageof 336